Literature DB >> 26838240

Helicobacter Species are Possible Risk Factors of Cholangiocarcinoma.

Soraya J Kaewpitoon1, Ryan A Loyd, Ratana Rujirakul, Sukij Panpimanmas, Likit Matrakool, Taweesak Tongtawee, Nusorn Kootanavanichpong, Prasit Pengsaa, Ponthip Kompor, Wasugree Chavengkun, Jirawoot Kujapun, Jun Norkaew, Sukanya Ponphimai, Natnapa Padchasuwan, Poowadol Polsripradist, Thawatchai Eksanti, Tanida Phatisena, Natthawut Kaewpitoon.   

Abstract

Several infectious agents are considered to be causes of cancer in human, mainly hepatitis B and C viruses, high-risk human pailloma viruses, Helicobacter pylori, Clonorchis sinensis, and Opisthorchis viverrini. Here we described the evident research and the association between Helicobacter spp. and biliary tract cancer particularly cholangiocarcinoma (CCA). Global epidemiological studies have suggested that Helicobacter spp. are possible risk factors for biliary tract diseases. Molecular studies support a linkage of Helicobacter spp. with CCA development. H. pylori, H. bilis, and H. hepaticus, are found in CCA, but the most common species are H. pylori and H. bilis. The type of CCA are associated with Helicobacter spp. include extrahepatic CCA, and common bile duct cancer. Up to the present, however, the results from different regions, materials and methods, sub-sites of cancer, and controls have not been consistent, thus introducing heterogeneity. Therefore, a comparison between co-Helicobacter spp.-CCA in the countries with low and high incident of CCA is required to settle the question. Furthermore, clarifying variation in the role of Helicobacter species in this CCA, including pathogenesis of CCA through enhanced biliary cell inflammation and proliferation, is necessary.

Entities:  

Mesh:

Year:  2016        PMID: 26838240     DOI: 10.7314/apjcp.2016.17.1.37

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Chinese liver fluke Clonorchis sinensis infection changes the gut microbiome and increases probiotic Lactobacillus in mice.

Authors:  Ju Yeong Kim; Eun-Min Kim; Myung-Hee Yi; Jinyoung Lee; Seogwon Lee; Younjee Hwang; Dongeun Yong; Woon-Mok Sohn; Tai-Soon Yong
Journal:  Parasitol Res       Date:  2019-01-08       Impact factor: 2.289

Review 2.  Liver fluke infection and cholangiocarcinoma: a review.

Authors:  Shuohan Zheng; Yuan Zhu; Zijun Zhao; Zhongdao Wu; Kamolnetr Okanurak; Zhiyue Lv
Journal:  Parasitol Res       Date:  2016-10-08       Impact factor: 2.289

3.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.

Authors:  Jessica L Petrick; Baiyu Yang; Sean F Altekruse; Alison L Van Dyke; Jill Koshiol; Barry I Graubard; Katherine A McGlynn
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 4.  The Curious Case of Cholangiocarcinoma: Opportunities for Environmental Health Scientists to Learn about a Complex Disease.

Authors:  William A Suk; Vajarabhongsa Bhudhisawasdi; Mathuros Ruchirawat
Journal:  J Environ Public Health       Date:  2018-08-09

Review 5.  New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.

Authors:  Maria Consiglia Bragazzi; Lorenzo Ridola; Samira Safarikia; Sabina Di Matteo; Daniele Costantini; Lorenzo Nevi; Vincenzo Cardinale
Journal:  Ann Gastroenterol       Date:  2017-11-02

6.  Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice.

Authors:  Guoxin Huang; Imran Khan; Xiaoang Li; Lei Chen; Waikit Leong; Leung Tsun Ho; W L Wendy Hsiao
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

Review 7.  Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis.

Authors:  Kimberly Hartl; Michael Sigal
Journal:  Int J Mol Sci       Date:  2020-10-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.